|
CHD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.420000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.492600E-01 |
| Normal-vs-Stage2 |
1.469600E-01 |
| Normal-vs-Stage3 |
2.129600E-01 |
| Normal-vs-Stage4 |
5.465000E-01 |
| Stage1-vs-Stage2 |
1.216620E-01 |
| Stage1-vs-Stage3 |
1.795970E-01 |
| Stage1-vs-Stage4 |
6.811000E-01 |
| Stage2-vs-Stage3 |
5.973400E-01 |
| Stage2-vs-Stage4 |
3.506400E-01 |
| Stage3-vs-Stage4 |
5.649000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.891400E-01 |
| Normal-vs-AfricanAmerican |
8.138600E-01 |
| Normal-vs-Asian |
8.551200E-01 |
| Caucasian-vs-AfricanAmerican |
5.130800E-01 |
| Caucasian-vs-Asian |
4.585600E-01 |
| AfricanAmerican-vs-Asian |
9.297800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.153000E-01 |
| Normal-vs-Female |
3.445600E-01 |
| Male-vs-Female |
3.457200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.061400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.502570E-01 |
| Normal-vs-Age(61-80Yrs) |
1.803790E-01 |
| Normal-vs-Age(81-100Yrs) |
8.794400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.634200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.908200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.895800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.972200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.082600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.043000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.646300E-02 |
| Classical-VS-Follicular |
2.5101000000749E-07 |
| Classical-VS-Other |
8.549400E-01 |
| Classical-VS-Normal |
5.844000E-01 |
| Tall-VS-Follicular |
1.788050E-01 |
| Tall-VS-Other |
4.159000E-01 |
| Tall-VS-Normal |
2.460600E-01 |
| Follicular-VS-Other |
1.526360E-01 |
| Follicular-VS-Normal |
3.917700E-03 |
| Other-VS-Normal |
9.655800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.713700E-02 |
| Normal-vs-N1 |
4.561000E-01 |
| N0-vs-N1 |
3.979200E-03 |
|
|
